David S. Goldstein
#88,585
Most Influential Person Now
David S. Goldstein's AcademicInfluence.com Rankings
David S. Goldsteinphilosophy Degrees
Philosophy
#3202
World Rank
#5237
Historical Rank
Logic
#1013
World Rank
#1630
Historical Rank
David S. Goldsteinbiology Degrees
Biology
#3943
World Rank
#5955
Historical Rank
Physiology
#71
World Rank
#185
Historical Rank
Download Badge
Philosophy Biology
David S. Goldstein's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Physiology University of California, San Francisco
Why Is David S. Goldstein Influential?
(Suggest an Edit or Addition)David S. Goldstein's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome (2011) (1157)
- Biochemical diagnosis of pheochromocytoma: which test is best? (2002) (1113)
- Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine (2004) (862)
- Takotsubo Cardiomyopathy: A New Form of Acute, Reversible Heart Failure (2008) (791)
- Low‐frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes (2011) (640)
- Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. (1981) (508)
- Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. (1986) (500)
- Plasma catecholamines and essential hypertension. An analytical review. (1983) (468)
- Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System (1985) (447)
- Cardiac sympathetic nerve function in congestive heart failure. (1996) (439)
- Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. (2003) (411)
- Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. (1988) (385)
- Sources and Significance of Plasma Levels of Catechols and Their Metabolites in Humans (2003) (384)
- Stress-Induced Norepinephrine Release in the Hypothalamic Paraventricular Nucleus and Pituitary-Adrenocortical and Sympathoadrenal Activity: In Vivo Microdialysis Studies (1995) (376)
- Cardiac Sympathetic Denervation in Parkinson Disease (2000) (352)
- Relationship between plasma norepinephrine and sympathetic neural activity. (1983) (344)
- Evolution of concepts of stress (2007) (321)
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression (2011) (320)
- Malignant pheochromocytoma: current status and initiatives for future progress. (2004) (320)
- Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. (1999) (312)
- Dopamine Biosynthesis Is Selectively Abolished in Substantia Nigra/Ventral Tegmental Area but Not in Hypothalamic Neurons in Mice with Targeted Disruption of the Nurr1 Gene (1998) (312)
- Allostasis, Homeostats, and the Nature of Stress (2002) (308)
- Sympathetic cardioneuropathy in dysautonomias. (1997) (306)
- Relative contribution of core and cutaneous temperatures to thermal comfort and autonomic responses in humans. (1999) (306)
- Dysautonomia in Parkinson's disease: neurocardiological abnormalities (2003) (294)
- Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. (2001) (283)
- Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. (1987) (274)
- Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity. (1998) (270)
- Low frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation (2011) (256)
- Neonatal diagnosis and treatment of Menkes disease. (2008) (253)
- The Electrocardiogram in Stroke: Relationship to Pathophysiological Type and Comparison with Prior Tracings (1979) (253)
- Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus (1994) (246)
- Orthostatic hypotension from sympathetic denervation in Parkinson’s disease (2002) (243)
- Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. (1988) (238)
- Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis. (2011) (237)
- Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesis (2012) (234)
- Association Between Supine Hypertension and Orthostatic Hypotension in Autonomic Failure (2003) (218)
- Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. (1994) (216)
- Plasma Norepinephrine in Essential Hypertension: A Study of the Studies (1981) (207)
- Circulatory, Plasma Catecholamine, Cortisol, Lipid, and Psychological Responses to a Real‐Life Stress (Third Molar Extractions): Effects of Diazepam Sedation and of Inclusion of Epinephrine with the Local Anesthetic (1982) (206)
- Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. (2005) (206)
- Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. (1987) (204)
- Phosphorylated α-Synuclein in Parkinson’s Disease (2012) (203)
- Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. (1993) (194)
- 6-[18F]Fluorodopamine Positron Emission Tomographic (PET) Scanning for Diagnostic Localization of Pheochromocytoma (2001) (191)
- Dysautonomias: Clinical Disorders of the Autonomic Nervous System (2002) (191)
- Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats. (1993) (191)
- Adrenal Responses to Stress (2010) (190)
- Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. (2004) (190)
- In vivo measurement of neuronal uptake of norepinephrine in the human heart. (1988) (182)
- Influence of Cigarette Smoking on Human Autonomic Function (1993) (182)
- Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system (1986) (173)
- Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. (2005) (170)
- Norepinephrine Precursor Therapy in Neurogenic Orthostatic Hypotension (2003) (170)
- A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism (2016) (167)
- Functional imaging of endocrine tumors: role of positron emission tomography. (2004) (157)
- Supine low-frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation (2009) (156)
- Patterns of plasma levels of catechols in neurogenic orthostatic hypotension (1989) (156)
- Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension. (1983) (156)
- Effects of Various Stressors on In Vivo Norepinephrine Release in the Hypothalamic Paraventricular Nucleus and on the Pituitary‐Adrenocortical Axis (1995) (156)
- Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b (1996) (155)
- Adrenomedullary, adrenocortical, and sympathoneural responses to stressors: a meta-analysis. (2008) (154)
- Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo (2014) (154)
- Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease (2013) (153)
- Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology. (1981) (152)
- Catecholamines and their metabolites. (1988) (151)
- Neurogenic Orthostatic Hypotension: A Pathophysiological Approach (2009) (150)
- Age-related thermoregulatory differences during core cooling in humans. (2000) (149)
- Comparison of Techniques for Measuring Baroreflex Sensitivity in Man (1982) (144)
- Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. (1995) (143)
- Laparoscopic correction of vesicoureteral reflux. (1993) (139)
- Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. (2008) (137)
- Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. (1995) (136)
- Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease (2012) (135)
- Stress, Catecholamines, and Cardiovascular Disease (1995) (131)
- Sympathetic Nervous Function in Human Heart as Assessed by Cardiac Spillovers of Dihydroxyphenylglycol and Norepinephrine (1992) (131)
- Positron emission tomographic imaging of cardiac sympathetic innervation and function. (1990) (128)
- Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders. (2014) (127)
- Age-dependence of hypertensive-normotensive differences in plasma norepinephrine. (1983) (125)
- Neurocirculatory Abnormalities in Parkinson Disease With Orthostatic Hypotension: Independence From Levodopa Treatment (2005) (124)
- Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? (1995) (121)
- Circulatory control mechanisms in vasodepressor syncope. (1982) (118)
- Dysautonomia in Parkinson disease. (2014) (117)
- Noradrenergic activation in the paraventricular nucleus during acute and chronic immobilization stress in rats: an in vivo microdialysis study (1992) (117)
- Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension (2003) (117)
- Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. (2002) (116)
- Association between cardiac denervation and parkinsonism caused by α‐synuclein gene triplication (2004) (115)
- Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease (2012) (114)
- Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies (2018) (114)
- Supine low-frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. (2007) (113)
- The Effect of Clozapine on Plasma Norepinephrine: Relationship to Clinical Efficacy (1994) (113)
- Endogenous serotonin stimulates striatal dopamine release in conscious rats. (1994) (111)
- Effects of Diazepam Premedication and Epinephrine‐Containing Local Anesthetic on Cardiovascular and Plasma Catecholamine Responses to Oral Surgery (1984) (111)
- Stress-induced activation of the sympathetic nervous system. (1987) (109)
- Effects of immobilization on in vivo release of norepinephrine in the bed nucleus of the stria terminalis in conscious rats (1995) (108)
- Cardiac sympathetic denervation preceding motor signs in Parkinson disease (2007) (106)
- Catechols in post‐mortem brain of patients with Parkinson disease (2011) (105)
- Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. (1985) (105)
- Sources and physiological significance of plasma dopamine sulfate. (1999) (104)
- Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies. (2012) (103)
- Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey. (1998) (103)
- Baroreflex Failure as a Late Sequela of Neck Irradiation (2003) (102)
- Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer’s disease (1999) (102)
- Cardiac Sympathetic Dysautonomia in Chronic Orthostatic Intolerance Syndromes (2002) (101)
- Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. (2005) (99)
- Corticotropin-releasing factor (CRF) produces analgesia in humans and rats (1987) (97)
- Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease (2011) (97)
- Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol. (1988) (96)
- Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans. (1993) (96)
- Phosphorylated alpha-Synuclein in Parkinson's Disease (2012) (96)
- Glucagon and Clonidine Testing in the Diagnosis of Pheochromocytoma (1991) (96)
- Relative contribution of core and skin temperatures to thermal comfort in humans (2000) (95)
- Plasma and cerebrospinal fluid neurochemical pattern in Menkes disease (1993) (95)
- Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. (2011) (94)
- Plasma and urinary catecholamines during the human ovulatory cycle. (1983) (94)
- Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. (1989) (93)
- Treatment of Malignant Pheochromocytoma with Combination Chemotherapy (1985) (92)
- Plasma norepinephrine pharmacokinetics during mental challenge. (1987) (92)
- Tumor necrosis factor: immune endocrine interaction. (1989) (91)
- Neuronal source of plasma dihydroxyphenylalanine. (1987) (89)
- Dopamine sulphate: an enigma resolved. (1999) (89)
- Progressive loss of cardiac sympathetic innervation in Parkinson's disease (2002) (89)
- Sympathoneural and adrenomedullary functional effects of &agr;2C-adrenoreceptor gene polymorphism in healthy humans (2005) (89)
- Clinical evaluation of impedance cardiography. (1986) (84)
- The extended autonomic system, dyshomeostasis, and COVID-19 (2020) (83)
- L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug. (2006) (83)
- Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma. (2001) (83)
- Derivation of urinary dopamine from plasma dihydroxyphenylalanine in humans. (1993) (82)
- Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity. (1994) (82)
- Orthostatic hypotension as an early finding in Parkinson’s disease (2006) (82)
- Catecholamines and stress. (2003) (81)
- Clonidine suppression testing in essential hypertension. (1985) (80)
- Interrelations between Sympathoadrenal System andHypothalamo‐Pituitary‐Adrenocortical/Thyroid Systemsin Rats Exposed to Cold Stress (1996) (80)
- Plasma Norepinephrine During Stress in Essential Hypertension (1981) (78)
- Prothrombotic Effects of Environmental Stress: Changes in Platelet Function, Hematocrit, and Total Plasma Protein * (1995) (76)
- Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model* (2005) (76)
- Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. (2004) (75)
- Is there a third peripheral catecholaminergic system? Endogenous dopamine as an autocrine/paracrine substance derived from plasma DOPA and inactivated by conjugation. (1995) (75)
- Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure. (2005) (75)
- Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. (1991) (75)
- Effects of Handling or Immobilization on Plasma Levels of 3,4‐Dihydroxyphenylalanine, Catecholamines, and Metabolites in Rats (1992) (75)
- Adrenergic and Endothelin B Receptor-Dependent Hypertension in Dopamine Receptor Type-2 Knockout Mice (2001) (73)
- Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo. (1989) (73)
- Plasma l-[3H]norepinephrine, d-[14C]norepinephrine, and d,l-[3H]isoproterenol kinetics in essential hypertension. (1983) (72)
- Dopamine‐β‐hydroxylase deficiency in humans (1990) (72)
- Clinical and therapeutic observations in aromatic l-amino acid decarboxylase deficiency (1999) (72)
- Measurement of regional neuronal removal of norepinephrine in man. (1985) (72)
- Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease. (2004) (72)
- Autonomic dysfunction in Parkinson disease. (2013) (71)
- Autonomic dysfunction in PD: A window to early detection? (2011) (71)
- Neuronal source of plasma dopamine. (2008) (70)
- Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans. (1989) (70)
- Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector. (2003) (70)
- Inhibition of peritoneal tumor-cell implantation: model for laparoscopic cancer surgery. (1993) (69)
- Stressor specificity of peripheral catecholaminergic activation. (1998) (69)
- Effects of single or repeated immobilization on release of norepinephrine and its metabolites in the central nucleus of the amygdala in conscious rats. (1993) (68)
- Generalized and neurotransmitter‐selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension (2008) (68)
- Catecholamines : bridging basic science with clinical medicine (1998) (67)
- Catecholamine-glucocorticoid interactions during surgical stress. (1987) (66)
- Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases. (2009) (66)
- Plasma dopa responses during stress: dependence on sympathoneural activity and tyrosine hydroxylation. (1992) (66)
- Simultaneous measurement of DOPA, DOPAC, and catecholamines in plasma by liquid chromatography with electrochemical detection. (1984) (65)
- Double-Blind , Placebo-Controlled , Crossover Study (2003) (65)
- Stress-induced norepinephrine release in the paraventricular nucleus of rats with brainstem hemisections: a microdialysis study. (1993) (65)
- High Urinary Dopa and Low Urinary Dopamine-to-Dopa Ratio in Salt-Sensitive Hypertension (1991) (65)
- Sympathetic innervation and function in reflex sympathetic dystrophy (2000) (64)
- Increased myocardial perfusion and sympathoadrenal activation during mild core hypothermia in awake humans. (2003) (64)
- Survival in synucleinopathies (2015) (64)
- Diagnosis and localization of pheochromocytoma. (2004) (64)
- Naloxone, fentanyl, and diazepam modify plasma beta‐endorphin levels during surgery (1986) (63)
- Successful early copper therapy in Menkes disease associated with a mutant transcript containing a small In-frame deletion. (1996) (63)
- Sympathoneural and adrenomedullary responses to mental stress. (2014) (63)
- Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases. (2011) (62)
- Plasma epinephrine levels and cardiovascular response to high administered doses of epinephrine contained in local anesthesia. (1987) (61)
- ATP7A gene addition to the choroid plexus results in long-term rescue of the lethal copper transport defect in a Menkes disease mouse model. (2011) (61)
- Cardiac denervation in patients with Parkinson disease. (2007) (61)
- Vesicular uptake blockade generates the toxic dopamine metabolite 3,4‐dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease (2012) (61)
- Sympathoadrenal imbalance before neurocardiogenic syncope. (2003) (60)
- A "pheo" lurks: novel approaches for locating occult pheochromocytoma. (2001) (60)
- Adrenalectomy augments in vivo release of norepinephrine in the paraventricular nucleus during immobilization stress. (1993) (60)
- Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus (2014) (59)
- Catecholaminergic effects of prolonged head-down bed rest. (1995) (58)
- Catecholamines 101 (2010) (58)
- Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues. (1989) (58)
- Levels of Catechols in Epileptogenic and Nonepileptogenic Regions of the Human Brain (1988) (57)
- Steady-state dopamine clearance in critically ill infants and children. (1988) (57)
- Derivation of urinary dopamine from plasma dopa. (1988) (57)
- Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytoma. (1986) (56)
- Mechanism of Peripheral Noradrenergic Stimulation by Clozapine (1998) (56)
- Diagnostic Localization of Pheochromocytoma (2002) (56)
- Association of anosmia with autonomic failure in Parkinson disease (2010) (55)
- Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein (2014) (55)
- Endocrine, renal, and hemodynamic responses to graded dopamine infusions in normal men. (1985) (55)
- Influence of Selective Inhibition of Monoamine Oxidase A or B on Striatal Metabolism of l‐DOPA in Hemiparkinsonian Rats (1995) (54)
- Pheochromocytoma: Rediscovery as a catecholamine-metabolizing tumor (2003) (54)
- Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1 (2021) (54)
- Plasma norepinephrine in essential hypertension (1984) (54)
- Estimation of intrasynaptic norepinephrine concentrations in humans. (1986) (53)
- Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. (2005) (52)
- Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. (1991) (52)
- Oral Yohimbine Increases Blood Pressure and Sympathetic Nervous Outflow in Hypertensive Patients (1993) (52)
- Simultaneous measurement of plasma and brain extracellular fluid concentrations of catechols after yohimbine administration in rats (1991) (51)
- Stimulation of the paraventricular nucleus modulates firing of neurons in the nucleus of the solitary tract. (1999) (51)
- Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy. (2000) (51)
- Noninvasive detection of sympathetic neurocirculatory failure (2000) (50)
- Decreased central and peripheral catecholaminergic activation in obese Zucker rats. (1995) (50)
- Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor (2002) (50)
- Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure (2004) (50)
- Impaired Basal and Restraint-Induced Epinephrine Secretion in Corticotropin-Releasing Hormone- Deficient Mice. (2000) (50)
- Autonomic uprising: the tilt table test in autonomic medicine (2019) (49)
- Leaky Catecholamine Stores: Undue Waste or a Stress Response Coping Mechanism? (2004) (49)
- Sympathoadrenomedullary inhibition by chronic glucocorticoid treatment in conscious rats. (1988) (49)
- Glucocorticoid‐induced sympathoinhibition in humans (1995) (49)
- Decreased stress responsivity of central and peripheral catecholaminergic systems in aged 344/N Fischer rats. (1995) (48)
- Benomyl, Aldehyde Dehydrogenase, DOPAL, and the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson’s Disease (2014) (48)
- Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans. (1989) (48)
- Production and metabolism of dopamine and norepinephrine in mesenteric organs and liver of swine. (1995) (47)
- Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans (1992) (47)
- Effects of injected sympathomimetic amines on plasma catecholamines and circulatory variables in man. (1983) (46)
- Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma (2007) (46)
- Sympathetic Reactivity During a Yohimbine Challenge Test in Essential Hypertension (1991) (46)
- Modulation of Rat Rotational Behavior by Direct Gene Transfer of Constitutively Active Protein Kinase C into Nigrostriatal Neurons (1998) (45)
- Dihydrocaffeic acid: a common contaminant in the liquid chromatographic-electrochemical measurement of plasma catecholamines in man. (1984) (45)
- Angiotensin II increases cytosolic calcium and stimulates catecholamine release in cultured bovine adrenomedullary cells. (1987) (45)
- Chronic Hypercortisolemia Inhibits Dopamine Synthesis and Turnover in the Nucleus accumbens: An in vivo Microdialysis Study (2002) (45)
- Differences in ATP7A gene expression underlie intrafamilial variability in Menkes disease/occipital horn syndrome (2007) (45)
- Autonomic dysfunction in Parkinson's disease. (2013) (44)
- Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine. (1991) (43)
- Plasma catecholamine and hemodynamic responses during isoproterenol infusions in humans (1986) (43)
- 3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells (2016) (43)
- Catecholaminergic inhibition by hypercortisolemia in the paraventricular nucleus of conscious rats. (1995) (43)
- The Autonomic Nervous System in Health and Disease (2000) (43)
- Relation of plasma norepinephrine and sympathetic traffic during hypotension in humans. (1990) (42)
- Cerebrospinal Fluid and Serum Levels of DOPA, Catechols, and Monoamine Metabolites in Patients with Epilepsy (1992) (42)
- Beat-to-beat blood pressure and heart rate responses to the Valsalva maneuver (2017) (42)
- Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens. (1987) (42)
- Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension. (2009) (40)
- Norepinephrine spillover from human adipose tissue before and after a 72-hour fast. (2002) (40)
- Source and Physiological Significance of Plasma 3,4‐Dihydroxyphenylalanine in the Rat (1988) (40)
- Glucocorticoids, sympathetic activity, and presynaptic alpha 2-adrenoceptor function in humans. (1995) (40)
- Relative Efficiencies of Plasma Catechol Levels and Ratios for Neonatal Diagnosis of Menkes Disease (2009) (40)
- Threshold for adrenomedullary activation and increased cardiac work during mild core hypothermia. (2002) (40)
- Glycine stimulates striatal dopamine release in conscious rats (1993) (39)
- Differential responses of components of the autonomic nervous system. (2013) (39)
- ENDOTHELIN CONCENTRATIONS IN CEREBROSPINAL FLUID IN DEPRESSIVE PATIENTS (1989) (39)
- Cerebrospinal fluid biomarkers of central dopamine deficiency predict Parkinson's disease. (2018) (38)
- Cardiorespiratory, sympathetic and biochemical responses to T-2 toxin in the guinea pig and rat. (1985) (38)
- Baroreflex sensitivity during operant blood pressure conditioning (1977) (38)
- Tracer norepinephrine kinetics: dependence on regional blood flow and the site of infusion. (1991) (37)
- The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in rats. (1994) (37)
- Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab (2009) (37)
- Local sympathetic denervation in painful diabetic neuropathy. (2002) (37)
- Impaired basal and restraint-induced epinephrine secretion in corticotropin-releasing hormone-deficient mice. (2000) (37)
- The sympathetic nervous system in man: its evaluation and the measurement of plasma NE (1984) (37)
- Adrenaline and the Inner World: An Introduction to Scientific Integrative Medicine (2006) (37)
- Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of its plasma kinetics. (1991) (36)
- Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells (2016) (36)
- Endogenous dopa and dopamine responses to dietary salt loading in salt-sensitive rats. (1991) (36)
- Reduced resting metabolic rate in patients with bulimia nervosa. (1991) (36)
- Hypercortisolemia inhibits yohimbine-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats. (1992) (36)
- Brainstem Hemisection Decreases Corticotropin‐Releasing Hormone mRNA in the Paraventricular Nucleus but not in the Central Amygdaloid Nucleus (1996) (35)
- 6-[18F]Fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function — studies in normal humans (1997) (35)
- Mechanisms of Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction (2020) (35)
- Dopamine-beta-hydroxylase deficiency in humans. (1990) (35)
- Effect of Ganglion Blockade on Cerebrospinal Fluid Norepinephrine (1987) (35)
- Neurotransmitter specificity of sympathetic denervation in Parkinson’s disease (2003) (35)
- The heart of PD: Lewy body diseases as neurocardiologic disorders (2017) (34)
- Stressor-specific activation of catecholaminergic systems: implications for stress-related hypothalamic-pituitary-adrenocortical responses. (1998) (34)
- Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy (2012) (34)
- Neurocirculatory Abnormalities in Chronic Orthostatic Intolerance (2005) (34)
- Central dopamine deficiency in pure autonomic failure (2008) (33)
- Validity of liquid chromatography with electrochemical detection for measuring dopamine in human plasma. (1981) (33)
- Role of CRH in Glucopenia‐lnduced Adrenomedullary Activation in Rats (1993) (33)
- Neuropharmacologic Distinction of Neurogenic Orthostatic Hypotension Syndromes (2006) (33)
- Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma (1989) (33)
- Sympathoadrenal medullary system and stress. (1988) (33)
- Effects of Continuous and Intermittent Cold (SART) Stress on Sympathoadrenal System Activity in Rats (1996) (33)
- Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation (2007) (33)
- Sympathetic Innervation in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Primate Model of Parkinson's Disease (2003) (32)
- Calcitonin gene-related peptide: a potent modulator of coronary flow. (1987) (32)
- Homeostatic systems, biocybernetics, and autonomic neuroscience (2017) (31)
- Metabolic fate of the sympathoneural imaging agent 6-[18F]fluorodopamine in humans. (1997) (31)
- Predominant Glandular Cholinergic Dysautonomia in Patients With Primary Sjögren's Syndrome (2015) (31)
- Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease (2015) (31)
- Effects of water immersion on sympathoadrenal and dopa-dopamine systems in humans. (1992) (31)
- Sympathetic neurocirculatory failure in Parkinson disease: Evidence for an etiologic role of alpha-synuclein. (2001) (30)
- Gender Differences in Brain Metabolic and Plasma Catecholamine Responses to Alpha2-Adrenoceptor Blockade (1997) (30)
- Indices of sympathetic vascular innervation in sympathectomized patients. (1986) (30)
- Sympathoadrenal contribution to plasma dopa (3,4-dihydroxyphenylalanine) in rats. (1992) (30)
- Effect of systemic alpha-2 adrenergic blockade on the morning increase in platelet aggregation in normal subjects. (1999) (30)
- Insulin resistance and autonomic function in traumatic lower limb amputees (1995) (30)
- Cardiac sympathetic denervation predicts PD in at-risk individuals. (2017) (30)
- Low sensitivity of glucagon provocative testing for diagnosis of pheochromocytoma. (2010) (30)
- Decreased sympathetic neuronal uptake in idiopathic orthostatic hypotension (1985) (29)
- A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease (2014) (29)
- Pure autonomic failure (2010) (29)
- Aging-related changes in cardiac sympathetic function in humans, assessed by 6-18F-fluorodopamine PET scanning. (2003) (29)
- α2-Adrenoceptor-mediated restraint of norepinephrine synthesis, release, and turnover during immobilization in rats (1999) (29)
- Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm. (1998) (29)
- Transcriptional Regulation of Phenylethanolamine N‐Methyltransferase in Pheochromocytomas from Patients with von Hippel–Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 (2006) (28)
- In vivo hypothalamic release and synthesis of catecholamines in spontaneously hypertensive rats. (1993) (28)
- Estimation of intrasynaptic norepinephrine concentrations at vascular neuroeffector junctions in vivo (1984) (28)
- Catecholamine research : from molecular insights to clinical medicine (2002) (28)
- Stress, Allostatic Load, Catecholamines, and Other Neurotransmitters in Neurodegenerative Diseases (2012) (28)
- Meta-analysis of nonselective versus beta-1 adrenoceptor-selective blockade in prevention of tilt-induced neurocardiogenic syncope. (2002) (27)
- How does homeostasis happen? Integrative physiological, systems biological, and evolutionary perspectives. (2019) (27)
- Catechol-O-Methyltransferase and Blood Pressure in Humans (2002) (27)
- BASAL GANGLIA INVOLVEMENT IN TEMPORAL LOBE EPILEPSY: A FUNCTIONAL AND MORPHOLOGIC STUDY (2008) (27)
- Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function. (1990) (27)
- Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man (2004) (27)
- Effects of Risperidone on the Peripheral Noradrenegic System in Patients with Schizophrenia: A Comparison with Clozapine and Placebo (2002) (26)
- Predictive value of plasma catecholamine levels in neonatal detection of Menkes disease (1993) (26)
- Sympathetic neuroimaging. (2013) (26)
- Effects of clonidine on renal sympathetic nerve activity and norepinephrine spillover. (1990) (26)
- The catecholaldehyde hypothesis: where MAO fits in (2019) (26)
- 3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine (2018) (26)
- Sympathoadrenomedullary hyper-responsiveness to yohimbine in juvenile spontaneously hypertensive rats. (1988) (26)
- Biomarkers, mechanisms, and potential prevention of catecholamine neuron loss in Parkinson disease. (2013) (26)
- Plasma norepinephrine and epinephrine levels in essential hypertension. (1984) (25)
- Plasma catecholamines and blood volume in native Andeans during hypoxia and normoxia (2006) (25)
- Release, metabolism and intraneuronal disposition of exogenous, endogenous and newly synthesized norepinephrine in the rat vas deferens. (1988) (24)
- Evidence for functional alpha 2-adrenoceptors on vascular sympathetic nerve endings in the human forearm. (1991) (24)
- Pattern of plasma levels of catecholamines in familial dysautonomia (1996) (24)
- Inverse relationship between plasma epinephrine and testosterone levels during acute glucoprivation in healthy men. (2001) (24)
- Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration. (2015) (24)
- Interrelationships among measures of autonomic activity and cardiovascular risk factors during orthostasis and the oral glucose tolerance test (1995) (24)
- Differential effects of low- and high-intensity lower body negative pressure on noradrenaline and adrenaline kinetics in humans. (1996) (24)
- Direct and reflexive effects of nitric oxide synthase inhibition on blood pressure. (2008) (23)
- Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies. (2016) (23)
- N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells (2017) (23)
- Cardiac sympathetic neuroimaging: summary of the First International Symposium (2009) (23)
- Cardiac Uptake-1 Inhibition by High Circulating Norepinephrine Levels in Patients with Pheochromocytoma (2004) (23)
- Effects of Carbidopa and Entacapone on the Metabolic Fate of the Norepinephrine Prodrug L‐DOPS (2011) (23)
- Dihydroxyphenylglycol and dihydroxymandelic acid during intravenous infusions of noradrenaline. (1987) (22)
- Effect of ionizing radiation on sympathetic nerve function in rat parotid glands. (1992) (22)
- Computer Models of Stress, Allostasis, and Acute and Chronic Diseases (2008) (22)
- Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy. (2017) (22)
- Linking Stress, Catecholamine Autotoxicity, and Allostatic Load with Neurodegenerative Diseases: A Focused Review in Memory of Richard Kvetnansky (2017) (22)
- Alpha-Synuclein Deposition Within Sympathetic Noradrenergic Neurons Is Associated With Myocardial Noradrenergic Deficiency in Neurogenic Orthostatic Hypotension (2019) (22)
- Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: Preliminary observations (2009) (22)
- Monoaminergic effects of high‐dose corticotropin in corticotropin‐responsive pediatric opsoclonus‐myoclonus (1998) (21)
- Pure autonomic failure without synucleinopathy (2017) (21)
- Neurotransmitters and stress (1990) (21)
- Pressor and depressor responses after cholinergic blockade in humans. (1984) (21)
- Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex (1993) (21)
- A test of the "epinephrine hypothesis" in humans. (1999) (21)
- Plasma Catechols - What Do They Mean? (1988) (21)
- Cardiovascular Autonomic Dysfunction (2005) (20)
- Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy. (2015) (20)
- Clinical Catecholamine Neurochemistry: A Legacy of Julius Axelrod (2006) (20)
- On the existence of functional beta‐adrenoceptors on vascular sympathetic nerve endings in the human forearm (1994) (20)
- Cardiac sympathetic hypo-innervation in familial dysautonomia (2008) (20)
- Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems. (2013) (20)
- The autonomic medical history (2017) (20)
- Cardiac ectopy in chronic autonomic failure (2010) (20)
- Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting - Part 2 (2021) (19)
- Computational modeling reveals multiple abnormalities of myocardial noradrenergic function in Lewy body diseases. (2019) (19)
- Diagnostic localization of pheochromocytoma: the coming of age of positron emission tomography. (2002) (19)
- Roles of cardiac sympathetic neuroimaging in autonomic medicine (2018) (19)
- Neuroscience and heart-brain medicine: The year in review (2010) (19)
- Differential Effects of Chemical Sympathectomy on Expression and Activity of Tyrosine Hydroxylase and Levels of Catecholamines and DOPA in Peripheral Tissues of Rats (2004) (19)
- Kinetic model for the fate of 6-[18F]fluorodopamine in the human heart: a novel means to examine cardiac sympathetic neuronal function (2001) (19)
- Epinephrine suppresses stress-induced increases in plasma immunoreactive beta-endorphin in humans. (1989) (19)
- Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids. (1986) (18)
- Imaging of the autonomic nervous system: focus on cardiac sympathetic innervation. (2003) (18)
- Altered norepinephrine regulation in bulimia: Effects of pharmacological challenge with isoproterenol (1990) (18)
- Renal sympathetic nerve activity and norepinephrine release in rats. (1989) (18)
- Haemodynamic actions of insulin (1998) (18)
- Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats. (1993) (18)
- Modified sample preparation for high-performance liquid chromatographic--electrochemical assay of urinary catecholamines. (1983) (18)
- DOPAL is transmissible to and oligomerizes alpha-synuclein in human glial cells (2016) (18)
- Partial cardiac sympathetic denervation after bilateral thoracic sympathectomy in humans. (2005) (18)
- Increased spillover of dopa into arterial blood during dietary salt loading. (1990) (18)
- Roles of catechol neurochemistry in autonomic function testing (2018) (18)
- Functional Neuroimaging of Sympathetic Innervation of the Heart (2004) (17)
- Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm. (1998) (17)
- Arteriovenous Differences in Plasma Concentrations of Catechols in Rats with Neuropathic Pain (1995) (17)
- 6-[Fluorine-18]fluorodopamine pharmacokinetics and dosimetry in humans. (1994) (17)
- Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope. (2006) (17)
- Catecholamine Phenotyping: Clues to the Diagnosis, Treatment, and Pathophysiology of Neurogenetic Disorders (1996) (17)
- Improved reliability of the liquid chromatography--electrochemical detection assay technique for measuring plasma epinephrine. (1981) (17)
- The physical examination as a window into autonomic disorders (2018) (17)
- Modified microdialysis probe for sampling extracellular fluid and administering drugs in vivo. (1993) (17)
- Pharmacologic and tracer methods to study sympathetic function in primary hypertension. (1989) (16)
- Plasma catecholamine levels in normal subjects and in patients with secondary hypertension. (1984) (16)
- Monoaminergic Effects of Folinic Acid, l‐DOPA, and 5‐Hydroxytryptophan in Dihydropteridine Reductase Deficiency (1995) (16)
- Cardiac sympathetic denervation without Lewy bodies in a case of multiple system atrophy. (2014) (16)
- Mechanisms of central hemodynamic and sympathetic regulation by mu opioid receptors: effects of dermorphin in the conscious rat. (1989) (16)
- Neurocardiology: therapeutic implications for cardiovascular disease. (2012) (16)
- Cardiac sympathetic denervation preceding motor signs in Parkinson disease (2009) (16)
- Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo (2021) (16)
- Cardiac Dysautonomia and Survival in Hereditary Transthyretin Amyloidosis. (2016) (16)
- Skin color, aging, and plasma L-dopa levels. (1989) (16)
- The wisdom of the body revisited: the adrenomedullary response to mild core hypothermia in humans. (2001) (16)
- Effects of elevated plasma epinephrine on glucose utilization and blood flow in conscious rat brain. (1997) (16)
- In utero copper treatment for Menkes disease associated with a severe ATP7A mutation. (2012) (16)
- Metabolic fate of injected radiolabelled dopamine and 2-fluorodopamine in rats (1990) (15)
- Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society (2019) (15)
- Dopamine beta-hydroxylase deficiency associated with mutations in a copper transporter gene. (1998) (15)
- Long-term trends in myocardial sympathetic innervation and function in synucleinopathies. (2019) (15)
- Differential actions of desipramine on sympathoadrenal release of noradrenaline and adrenaline. (1995) (15)
- Cytosolic calcium in platelets of spontaneously hypertensive rats. (1986) (15)
- Cerebrospinal Fluid-Directed rAAV9-rsATP7A Plus Subcutaneous Copper Histidinate Advance Survival and Outcomes in a Menkes Disease Mouse Model (2018) (15)
- 123I-MIBG scintigraphy of catecholamine systems: impediments to applications in clinical medicine (2000) (15)
- Attenuated Pre‐ejection Period Response to Tyramine in Patients with Cardiac Sympathetic Denervation (2008) (14)
- Differential inhibition of alpha adrenoceptor-mediated pressor responses by rat atrial natriuretic peptide in the pithed rat. (1985) (14)
- Influence of St John's wort on catecholamine turnover and cardiovascular regulation in humans (2004) (14)
- The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein (2015) (14)
- State-related changes in norepinephrine regulation in anorexia nervosa (1989) (14)
- Effects of a peripherally acting α2-adrenoceptor antagonist (L-659,066) hemodynamics and plasma levels of catechols in conscious rats (1989) (14)
- Diagnosis of copper transport disorders. (2011) (14)
- Cardiovascular aspects of Parkinson disease. (2006) (14)
- Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension. (2003) (14)
- Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome. (2007) (14)
- Plasma catecholamines and renin during operant blood pressure conditioning in baboons (1981) (13)
- Plasma catecholamines in clinical studies of cardiovascular diseases. (1984) (13)
- Contamination of the norepinephrine prodrug droxidopa by dihydroxyphenylacetaldehyde. (2010) (13)
- Estimation of striatal dopamine spillover and metabolism in vivo (2000) (13)
- Prostate cancer screening: Role of digital rectal examination and prostate-specific antigen (1994) (13)
- Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha-synuclein in chronic autonomic failure (2018) (13)
- Mechanisms underlying cardiovascular defense reaction evoked by dorsal periaqueductal gray stimulation. (1993) (13)
- On the existence of functional angiotensin II receptors on vascular sympathetic nerve terminals in the human forearm (1995) (13)
- Production and reversal of DOCA-salt hypertension in baboons. (1987) (13)
- Correlates of urinary excretion of catechols in Humans (1993) (12)
- Stress and sodium hypertension in baboons: neuroendocrine and pharmacotherapeutic assessments. (1991) (12)
- What ARE Parkinson disease? Non-motor features transform conception of the shaking palsy (2012) (12)
- Local sympathetic function in human skeletal muscle and adipose tissue assessed by microdialysis (2002) (12)
- Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss (2019) (12)
- Sympathetic Nervous System (2007) (12)
- The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know (2021) (12)
- Effects of ouabain on cytosolic calcium in lymphocytes, platelets and adrenomedullary cells. (1987) (11)
- Plasma Catechols in Familial Dysautonomia: A Long-term Follow-up Study (2008) (11)
- L‐Threo‐Dihydroxyphenylserine corrects neurochemical abnormalities in a menkes disease mouse model (2013) (11)
- Triiodothyronine attenuates estradiol-induced increases in dopamine D-2 receptor number in rat anterior pituitary (1996) (11)
- Neurocirculatory regulation in cortisol-induced hypertension. (1989) (11)
- Cardiac sympathetic neuroimaging to distinguish multiple system atrophy from Parkinson disease (2001) (11)
- Isoproterenol infusion test in anorexia nervosa: assessment of pre- and post-beta-noradrenergic receptor activity. (1990) (11)
- New approaches to evaluate sympathoadrenal system activity in experiments on earth and in space. (1994) (11)
- Dopamine contamination of infused tyramine. (2005) (10)
- Autoimmunity-associated autonomic failure with sympathetic denervation (2017) (10)
- Implications of plasma levels of catechols in the evaluation of sympathoadrenomedullary function. (1989) (10)
- THE EFFECT OF DOCARPAMINE, A DOPAMINE PRO-DRUG, ON BLOOD PRESSURE AND CATECHOLAMINE LEVELS IN SPONTANEOUSLY HYPERTENSIVE RATS (2000) (10)
- Carotid artery thickening and neurocirculatory abnormalities in de novo Parkinson disease (2014) (10)
- Dosimetric estimates for clinical positron emission tomographic scanning after injection of [18F]-6-fluorodopamine. (1991) (10)
- Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia (2004) (10)
- Catecholamines in the Periphery (1997) (10)
- Stress, Allostatic Load, Catecholamines, and Other Neurotransmitters in Neurodegenerative Diseases (2011) (10)
- Catecholamine Receptors and Signal Transduction (1997) (10)
- Pleiotropic neuropathological and biochemical alterations associated with Myo5a mutation in a rat Model (2018) (9)
- A single column, rapid quality control procedure for 6-[18F]fluoro-L-dopa and 6-[18F]fluorodopamine PET imaging agents. (1991) (9)
- Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson’s disease through mitochondrial dysfunction (2020) (9)
- Chronic effects of high salt intake and conflict stress on blood pressure in primates (1991) (9)
- Isoproterenol Kinetics in Essential Hypertension (9)
- Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action. (1998) (9)
- Plasma levels of catechols after fasting in intact or adrenal-demedullated rats. (1989) (9)
- Plasma sulfoconjugated dopamine levels are normal in patients with autonomic failure. (1996) (9)
- Sympathetic adrenergic blockade effects upon operantly conditioned blood pressure elevations in baboons (1977) (9)
- CLINICAL EVALUATION OF THE AUTONOMIC NERVOUS SYSTEM (2007) (9)
- Neural circulatory control in the hyperdynamic circulatory state syndrome. (1985) (9)
- Pulse-wave model of brachial arterial pressure modulation in aging and hypertension. (1986) (9)
- The “Sick-but-not-Dead” Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases (2020) (8)
- Position Paper: The Sympathetic Nervous System and Hypertension (1981) (8)
- Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy (2015) (8)
- COMPARISON OF NORADRENALINE AND ISOPRENALINE REMOVAL IN THE CANINE HINDLIMB AND KIDNEY (1986) (8)
- Plasma levels of catecholamines and corticotrophin during acute glucopenia induced by 2-deoxy-D-glucose in normal man (1992) (8)
- On the Dialectic Between Molecular Biology and Integrative Physiology: Toward a New Medical Science (2015) (8)
- Renal effects of L-DOPA in heart failure. (1999) (8)
- Association of innervation-adjusted alpha-synuclein in arrector pili muscles with cardiac noradrenergic deficiency in autonomic synucleinopathies (2019) (8)
- Simultaneous determination of endogenous catechols and exogenous 2- and 6-fluorinated catechols in tissue and plasma using liquid chromatography with electrochemical detection. (1988) (8)
- Quantitative indices of baroreflex-sympathoneural function: application to patients with chronic autonomic failure (2014) (7)
- Temporary elimination of orthostatic hypotension by norepinephrine infusion (2012) (7)
- Substantial renal conversion of l-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension (2018) (7)
- Modification of cerebral cortical noradrenaline release by chronic inhibition of MAO-A. (1994) (7)
- Functional α3-glycine receptors in rat adrenal (1995) (7)
- Plasma catecholamine, renin activity, and ACTH responses to the serotonin receptor agonist DOI in juvenile spontaneously hypertensive rats. (1993) (6)
- Effects of a peripherally acting alpha 2-adrenoceptor antagonist (L-659,066) on hemodynamics and plasma levels of catechols in conscious rats. (1989) (6)
- Molecular and biochemical characterization of Mottled-dappled, an embryonic lethal Menkes disease mouse model. (2014) (6)
- Effects of nafazatrom on cardiovascular, sympathetic, and endocrine responses to hemorrhagic shock in conscious rats. (1985) (6)
- Sympathetic Nervous System Physiology and Pathophysiology in Coping with the Environment (2011) (6)
- Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies (2020) (6)
- Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies (2021) (6)
- Acute alpha 2 blockade by idazoxan increases insulin and lowers plasma glucose during positron emission tomography. (1997) (6)
- Cardiac 18F‐Dopamine PET Distinguishes PD with Orthostatic Hypotension from Parkinsonian MSA (2021) (6)
- Measurement of homovanillic acid in small volumes of plasma using liquid chromatography with electrochemical detection. (1988) (6)
- Allostasis, Homeostasis, and the Costs of Physiological Adaptation: Merging of the Homeostat Theory with the Concept of Allostatic Load (2004) (6)
- Dietary Salt Intake and the Clonidine Suppression Test (1987) (5)
- Peripheral Dopamine Systems (2004) (5)
- Cardiovascular Autonomic Dysfunction in Parkinson’s Disease (2013) (5)
- Spinal cord stimulation for chronic reflex sympathetic dystrophy (2004) (5)
- Adrenomedullary Response to Glucagon in Patients with Primary Sjögren’s Syndrome (2012) (5)
- Effects of hypercortisolemia or hyperinsulinemia on neurochemical indices of catecholamine release and synthesis in conscious rats. (1995) (5)
- “Sick-but-not-dead”: multiple paths to catecholamine deficiency in Lewy body diseases (2020) (5)
- [Disruption of the D(2) dopamine receptor produces adrenergic and endothelin B receptor-dependent hypertension]. (2002) (5)
- Visceral Learning: Cardiovascular Conditioning in Primates (1977) (5)
- α‐Synuclein Deposition in Sympathetic Nerve Fibers in Genetic Forms of Parkinson's Disease (2021) (5)
- Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society (2020) (4)
- Autoimmune autonomic failure in a patient with myeloma-associated Shy-Drager syndrome (1996) (4)
- Effect of morphine on the hemodynamic and neuroendocrine responses to hemorrhage in conscious rats. (1989) (4)
- Plasma levels of catechols during reflexive changes in sympathetic nerve activity (1989) (4)
- AUTONOMIC FAILURE IN NEURODEGENERATIVE DISORDERS (2007) (4)
- Genotype and vascular phenotype linked by catecholamine systems. (2008) (4)
- Glucagon does not affect catecholamine release in primary cultures of bovine adrenal chromaffin cells. (2005) (4)
- Species-dependent differences in recovery of 3,4-dihydroxybenzylamine in assays of plasma catecholamines. (1988) (4)
- Sympathetic Noradrenergic and Adrenomedullary Hormonal Systems in Stress and Distress (2009) (4)
- The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease (2021) (4)
- Pathophysiological significance of increased α-synuclein deposition in sympathetic nerves in Parkinson’s disease: a post-mortem observational study (2021) (4)
- 3,4-Dihydroxyphenylacetaldehyde is more efficient tha n dopamine in oligomerizing and quinonizing alpha-synuclein (2019) (4)
- Genotype and phenotype in familial dysautonomia. (1998) (4)
- Cardiac sympathetic innervation and vesicular storage in pure autonomic failure (2020) (4)
- Sympathoneural and skeletal muscle contributions to plasma dopa responses in pithed rats. (1991) (4)
- Method for measuring endogenous 3-O-methyldopa in urine and plasma. (1991) (4)
- Simultaneous liquid-chromatographic determination of plasma catecholamines and metabolites. (2009) (4)
- Rapid liquid chromatographic methods for assay of norepinephrine, epinephrine, and dopamine in biological fluids and tissues (1984) (3)
- Plasma Catechols After Eating Olives (2017) (3)
- Vasodilation during systemic tyramine administration response. (2004) (3)
- Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases (2021) (3)
- Cerebrospinal Fluid Biomarkers of Central Catecholamine Deficiency in Parkinson Disease and Other Synucleinopathies (2014) (3)
- Catecholamines and neurocardiogenic syncope. (1998) (3)
- Evidence of reduced efferent renal sympathetic innervation after chemical renal denervation in humans. (2021) (3)
- Hypertension Increases Cerebral 6-18F-Fluorodopa–Derived Radioactivity (2009) (3)
- A new sign of sympathetic neurocirculatory failure: premature ventricular contraction as a “one-beat Valsalva maneuver” (2000) (3)
- Vasodilation During Systemic Tyramine Administration (2004) (3)
- Do indices of baroreflex failure and peripheral noradrenergic deficiency predict the magnitude of orthostatic hypotension in Lewy body diseases? (2021) (3)
- Sex-Specific Alterations in Dopamine Metabolism in the Brain after Methamphetamine Self-Administration (2022) (3)
- Systemic hemodynamics during orthostasis in multiple system atrophy. (2016) (2)
- Autonomic function tests: introduction to the series (2017) (2)
- Relationship of supine hypertension to baroreflex-cardiovagal and baroreflex-sympathoneural dysfunction in chronic autonomic failure (2015) (2)
- Catecholamines and Neurocarondiogenic Syncope (1997) (2)
- Instrumental cardiovascular conditioning: A review (1979) (2)
- Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity. (1998) (2)
- Stress and the “extended” autonomic system (2021) (2)
- Coronary vascular resistance in primary chronic autonomic failure (2006) (2)
- Pharmacokinetics and Dosimetry in Humans (1994) (2)
- Painful sweating (2004) (2)
- Does acetylcholinesterase inhibition affect catecholamine secretion by adrenomedullary cells? (2004) (2)
- Novel Catecholaminergic Systems (1997) (2)
- 10 – Noradrenergic Neurotransmission (2004) (2)
- Molecular, Clinical and Biochemical Characterization of a Mild Menkes Phenotype Associated with a Novel Missense Mutation (Ala1362Asp) in the ATP7A Copper Transport Gene. † 612 (1997) (2)
- Is pure autonomic failure a distinct nosologic entity? (2017) (2)
- What new can we learn from cardiac sympathetic neuroimaging in synucleinopathies? (2022) (2)
- Corrigendum to "Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy" [Parkinsonism Relat. Disord. 35 (2017) 88-91]. (2017) (1)
- Room C, 10/17/2000 9: 00 AM - 11: 00 AM (PS) Sympathoneural and Adrenomedullary Responses to Cold Stress in Awake Humans A-355 (2000) (1)
- Local Sympathetic Denervation in Painful Diabetic (2002) (1)
- NEONATOLOGY FRIDAY, MAY 29TH, 1987 SOUTH BALLROOM 10: 45–12 (1987) (1)
- Central Catecholamines and the Control of Sympathetic Tone (1992) (1)
- 604 The Effects of clozapine on plasma norepinephrine kinetics in schizophrenic patients (1997) (1)
- ATRIAL NATRIURETIC PEPTIDE: THE RELATIONSHIP WITH VOLUME OVERLOAD, ATRIAL TACHYCARDIA AND CRITICAL ILLNESS (1987) (1)
- Correction to: The catecholaldehyde hypothesis: where MAO fits in (2019) (1)
- Divergent relationship of body mass index with plasma norepinephrine and epinephrine (2004) (1)
- MECHANISMS OF CARDIAC SYMPATHETIC DENERVATION IN PARKINSON DISEASE (2010) (1)
- COMPARISON OF PLASMA CATECHOL LEVELS FROM CORD BLOOD AND INFANT VENOUS BLOOD IN THE NEONATAL DIAGNOSIS OF MENKES DISEASE. † 861 (1996) (1)
- Stimulation of the paraventricular nucleus modulates firing of neurons in the nucleus of the solitary tract. (1999) (1)
- The Sympathetic Nervous and the Adrenomedullary Hormonal Systems: Differential Responses to Stressors (1998) (1)
- P1.217 Decreased putamen aldehyde dehydrogenase in Parkinson disease (2009) (1)
- Is 18F-DOPA a valid cardiac sympathetic neuroimaging agent? (2022) (1)
- Multiple catechols in human plasma after drinking caffeinated or decaffeinated coffee. (2021) (1)
- Irwin J Kopin (2017) (1)
- Chemical mediators of autonomic nervous system activity. (1993) (1)
- Biochemical Neuroadaptations in the Rat Striatal Dopaminergic System after Prolonged Exposure to Methamphetamine Self-Administration (2022) (1)
- Principles of Autonomic Medicine Version 1.0 (2015) (1)
- Catecholamine receptors and signal transduction. Overview. (1998) (1)
- Prevalence of anti-locus coeruleus immunoreactivity in CSF of patients with autonomic failure (2006) (1)
- Baroreflex-sympathoneural without baroreflex-cardiovagal failure in neurogenic orthostatic hypotension. (2023) (1)
- Catecholamines in the periphery. Overview. (1998) (1)
- Antihypertensive Therapy with Ketanserin: Metabolic and Hemodynamic Effects (1988) (1)
- P-508: Association between supine hypertension and orthostatic hypotension in chronic autonomic failure (2003) (1)
- IPSC-derived dopaminergic neurons from patients with Gaucher disease and Parkinsonism demonstrate the potential of a new glucocerebrosidase chaperone (2016) (1)
- Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from human induced pluripotent stem cells (2021) (1)
- Response to: Human papillomavirus (HPV) vaccine safety concerning POTS, CRPS and related conditions (2019) (1)
- Monoamine oxidase inhibition decreases endogenous production of the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL) (2015) (1)
- 2.144 CSF BIOMARKERS OF CENTRAL CATECHOLAMINE DEFICIENCY IN THE DIAGNOSIS OF PARKINSON DISEASE AND OTHER SYNUCLEINOPATHIES (2012) (0)
- Biomarkers, Mechanisms, and Treatment of Autonomic Failure in Parkinson Disease and Related Disorders (2011) (0)
- Metabolic and hemodynamic effects of antihypertensive treatment with ketanserin. (1988) (0)
- Cardiac Sympathetic Denervation: A Biomarker of Lewy Body Diseases (2014) (0)
- DOPAL oligomerizes alpha-synuclein in glial cells. Implications for the pathogenesis of multiple system atrophy (2015) (0)
- Session I: Pathways Involved in Neuromodulation of Risks in Coronary Artery Disease ROBERT M. CARNEY and KENNETH E. FREEDLAND Depression and heart rate variability in patients with coronary heart disease MICHAEL S. LAUER Autonomic function and prognosis (2009) (0)
- THE ROLE OF ATRIAL NATRIURETIC PEPTIDE (ANP) IN CONGENITAL HEART DISEASE (1987) (0)
- Plasma Norepinephrine in Patients with Essential Hypertension and in Normotensives During Standing Reference Bertel (2005) (0)
- to thermal comfort and autonomic responses in humans Relative contribution of core and cutaneous temperatures (2013) (0)
- Neurogenic Orthostatic Hypotension A Pathophysiological Approach Contemporary Reviews in Cardiovascular Medicine (2008) (0)
- Temperature‐Induced Changes to Aquaporin Localization in the Freeze‐Tolerant Cope's Gray Treefrog (2017) (0)
- Stereospecific differences in norepinephrine metabolism in patients with orthostatic hypotension (1984) (0)
- Novel catecholaminergic systems. Overview. (1998) (0)
- VASOVAGAL SYNCOPE AND SYMPATHETIC ACTIVITY 757 (2017) (0)
- ( BCDB ) A Subclass of Insulator Binding Sites Establish Dense Clusters to Delineate Topologically Associating Domains 4 : 15 (2014) (0)
- OR-15: Labile hypertension from baroreflex failure: a late sequela of neck irradiation (2003) (0)
- Clinical Studies Estimation of Intrasynaptic Norepinephrine Concentrations in Humans (2005) (0)
- Cardiac Sympathetic Neuroimaging in DLB (2014) (0)
- Cardiovascular Emotional Conditioning in the Baboon: Do Chronically Repeated Pressor Episodes Cause Sustained Elevations in Blood Pressure? (2022) (0)
- Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection (2023) (0)
- Correction to: Baroreflex‑sympathoneural dysfunction characterizes at‑risk individuals with preclinical central Lewy body diseases (2023) (0)
- ATRIAL NATRIURETIC PEPTIDE (ANP): THE RELATIONSHIP WITH VOLUME, TACHYCARDIA AND CRITICAL ILLNESS (1987) (0)
- Low CSF DOPAC and DHPG levels are biomarkers of parkinsonian disorders. (2015) (0)
- Hypertrophic Cardiomyopathy Myocardial Perfusion and Sympathetic Innervation in Patients With Hypertrophic Cardiomyopathy (2016) (0)
- Patients as a Scientific Resource: Comments on Receiving the Ahrens Award (2011) (0)
- Adrenomedullary Response to Glucagon in Patients with Primary Sjögren’s Syndrome (2012) (0)
- Determinants of Thermal Discomfort and the Thermoregulatory Response: Relative Contribution of Core and Skin-Surface Temperatures (1998) (0)
- Clinical Sympathetic Imaging (2012) (0)
- Functional alpha 3-glycine receptors in rat adrenal. (1995) (0)
- S9.4 Parkinson disease with orthostatic hypotension: Distinctions from Parkinson disease without orthostatic hypotension and from pure autonomic failure (2009) (0)
- GOLDSTEIN TABLE 1 Arterial baroreflex sensitivity as measured by several techniques in hypertensive patients and normotensive control subjects Hypertensive subjects Normotensive subjects (0)
- Contributions In Vivo Hypothalamic Release and Synthesis of Catecholamines in Spontaneously Hypertensive Rats (2005) (0)
- Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. (2010) (0)
- N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells (2017) (0)
- Sweating and sympathoadrenal imbalance precede tilt-induced neurally mediated hypotension (2015) (0)
- Effects of atrial natriuretic factor on urinary concentration of catecholamines and renin secretion in dogs. (1988) (0)
- endings in the human forearm Evidence for functional alpha 2-adrenoceptors on vascular sympathetic nerve (2011) (0)
- Linking Stress, Catecholamine Autotoxicity, and Allostatic Load with Neurodegenerative Diseases: A Focused Review in Memory of Richard Kvetnansky (2017) (0)
- 3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells (2016) (0)
- Sympathetic Innervation in the MPTP Primate Model of Parkinson’s Disease (2003) (0)
- Chapter 6 – Noradrenergic Neurotransmission (2012) (0)
- Abstract 18074: Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction: Is It actually a Matter of Chronotropic Reluctance? (2016) (0)
- Reduced Release of Atrial Natriuretic Peptides to Acute Volume Expansion in Conscious Young Spontaneously Hypertensive Rats (1986) (0)
- Baroreflex-sympathoneural dysfunction characterizes at-risk individuals with preclinical central Lewy body diseases (2022) (0)
- responses in humans temperatures to thermal comfort and autonomic Relative contribution of core and cutaneous (2015) (0)
- Sympathetic cardioneuropathy in dysautonomias. (1997) (0)
- American Journal Oj Physiology Published by the American Physiological Society (0)
- 114 Plasma metanephrines in the diagnosis of pheochromocytoma (1993) (0)
- 24 CARDIAC SYMPATHETIC DENERVATION PRECEDING PARKINSON DISEASE. (2006) (0)
- The Eighth International Catecholamine Symposium Overview of the Eighth International Catecholamine Symposium (1997) (0)
- Author response: Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss (2020) (0)
- 179. Mechanism of peripheral noradrenergic stimulation by risperidone (2000) (0)
- Cardiac Sympathetic Denervation Preceding Parkinson Disease (2006) (0)
- Fluorodop amine Pharmacokinetics and Dosimetry in Humans (2006) (0)
- Effects of risperidone on catecholaminergic function in patients with schizophrenia (2000) (0)
- Progressive Noradrenergic Degeneration in Mice with Reduced Expression of the Vesicular Monoamine Transporter (VMAT2) (2014) (0)
- Accelerated intraneuronal catecholamine loss related to decreased vesicular uptake in lewy body diseases (2011) (0)
- Modeling the Progression of Cardiac Catecholamine Deficiency in Lewy Body Diseases (2022) (0)
- Comprar Stress, Neurotransmitters, and Hormones: Neuroendocrine and Genetic Mechanisms | RICHARD KVETNANSKY | 9781573316927 | Wiley (2008) (0)
- Willie Sutton’s Getaway Car and the Pathogenesis of Parkinson Disease (2014) (0)
- Elevated plasma norepinephrine and DOPA spillover in repeatedly stressed rats (1992) (0)
- Biomarkers and mechanisms of central catecholamine deficiency in MSA (2015) (0)
- THE ROLE OF ATRIAL NATRIURETIC PEPTIDE IN CONGENITAL HEART DISEASE (1987) (0)
- Stressor-Specific Activation of Catecholamine Systems in Humans (2002) (0)
- Case 27-2004: multiple-system atrophy. (2004) (0)
- Original Contributions In Vivo Hypothalamic Release and Synthesis of Catecholamines in Spontaneously Hypertensive Rats (2005) (0)
- 1 st Joint Meeting of the International Society for Autonomic Neuroscience and the American Autonomic Society (2011) (0)
- 2.024 ACCELERATED INTRANEURONAL CATECHOLAMINE LOSS RELATED TO DECREASED VESICULAR UPTAKE IN PATIENTS WITH LEWY BODY DISEASES (2012) (0)
- Sympathoadrenal function in patients with paroxysmal hypertension (2006) (0)
- Plasma Metanephrines: the Optimal Diagnostic Tool for Pheochromocytoma? (2004) (0)
- Tandem Duplication of Exons 1-7 Neither Impairs ATP7A Expression Nor Causes a Menkes Disease Phenotype. (2015) (0)
- 1313 International Symposium on the Autonomic Nervous System (2002) (0)
- InVivoMeasurementofNeuronal Uptakeof Norepinephrine intheHumanHeart (1988) (0)
- Room B, 10/17/2000 9: 00 AM - 11: 00 AM (PS) Cardiac Parasympathetic Function during Normothermic and Hypothermic Intravascular Volume Loading A-169 (2000) (0)
- Atrial Natriuretic Factor (ANF) and Plasma Catecholamines (PC) in Rats with Acute and Chronic Renal Failure (1986) (0)
- 995-19 The Impact of Mental Stress and α-Adrenergic Activation on the Microcirculation of Patients with Coronary Artery Disease (1995) (0)
- EFFECT OF DEBRISOQUIN ON CATECHOLAMINE (CA) SYNTHESIS AND METABOLITE FORMATION. (1992) (0)
- 197. Survival, Growth, and Neurobehavioral Outcomes in a Mouse Model of Menkes Disease With CSF-Directed AAV9 and Subcutaneous Copper Histidine (2015) (0)
- Pathophysiological significance of increased α-synuclein deposition in sympathetic nerves in Parkinson’s disease: a post-mortem observational study (2022) (0)
- Catecholamines in the Brain and Responses to Environmental Challenges (2011) (0)
- Obituary (2017) (0)
- Central and Peripheral Norepinephrine Secretion in Major Depression is Activated, as Assessed by 24 hour CSF and Plasma Sampling (2014) (0)
- Dopamine Contamination of Infused Tyramine, Court- (2005) (0)
- Hereditary dysautonomias: current knowledge and collaborations for the future (2003) (0)
- Glucocorticoids, Sympathetic Activity, and Presynaptic a^-Adrenoceptor Function in Humans (2017) (0)
- Norepinephrine reuptake blockade to treat neurogenic orthostatic hypotension (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David S. Goldstein?
David S. Goldstein is affiliated with the following schools:
